Inhibition of the fibroblast growth factor receptor (FGFR) pathway: The current landscape and barriers to clinical application

Young Kwang Chae^*, Keerthi Ranganath, Peter S. Hammerman, Christos Vaklavas, Nisha Mohindra, Aparna Kalyan, Maria Matsangou, Ricardo Costa, Benedito Carneiro, Victoria M. Villaflor, Massimo Cristofanilli, Francis J. Giles

^*Corresponding author for this work